The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Hello fellow SNG fans,
I have been researching Dr Jha who gave evidence to the Senate committee this week that SNG is supported by op warp speed and/or Activ2, depending how you interpret the English grammar, as previously discussed here. If you missed it, here’s the link, see page 3:
https://www.hsgac.senate.gov/imo/media/doc/Testimony-Jha-2020-11-19.pdf
Dr Jha is Dean of The public health school At Brown University and is often being interviewed on Us news about covid.
It turns out this hearing was quite political. The senators are trying to resurrect hydroxychloroquine, which has been proven not to work. Dr Jha is an advocate of scientific data not opinion so he was trying to show some scientifically proven alternative treatments. This could be how the info leaked out unintentionally, or alternativek he could have be trying to claim US credit, he seems a credible expert though. See what you think:
https://mobile.twitter.com/ashishkjha/status/1329646432958156801
I love this board. The research is too notch, the intelligent discussion, tips and diversity of experience is fantastic. At the moment this board is pants.
Please can we take a step back and look at the situation:
1) this company communicates when they have something big to say. If you want a company that tell you when they have a biscuit with their cup of tea, you won’t get that here. Relax and wait for an RNS, or move along.
2) we know some big things are coming... possibly Op warp speed and/or Activ 2 trial, possibly $3.6bn revenue next year in stockpiling alone... and that’s just the last two days. Either you believe in the medium term prospects here, so hold patiently (or top up), or if you don’t believe then sell.
3) the share price is volatile. There are lots of nervous PI’s who think they are holding a covid treatment stock in the face of magical vaccines, the market has priced it accordingly. They have missed the broad spectrum anti viral (viral penicillin). Either sit with the disparity or cut your losses and sell
4) this is a small company of 15 people. RM was good on the webinar but looked tired to me. He is working his a$$ off to get this out. If you have a minor question email consilium, don’t disturb RM who is bloody busy! Pmjh and the researchers can send RM useful articles and links, don’t everyone flood RM with stuff, he is just being polite.
5) finally, if a random troll wanders through our board, someone please factually refute it, then everyone can “like” the comment and we can move on. We let these idiots highjack our board frequently.
I know that some of our admired researchers and knowledgeable posters have stopped coming here because they have to wade through so many complaints. Yes that stuff annoys us all, but we can’t solve it. Let’s share research and intelligent discussion here.
Please don’t give me replies about how important these complaints are really, I’m not interested. I believe in this company and I want our board back.
I would like to apologise to Miggy for not listening more closely. I just hadn’t realised the stockpiling potential here.
The SP is getting battered as the market has labelled this a covid treatment whose days are numbered by a magical vaccine. In reality, we are a broad spectrum antiviral, one use is the current global pandemic.
This will be the easiest conversation with every government around the world to insure against future pandemics and they are focused on that right now.
Make no wonder RM shrugs his shoulders at the vaccine. We should too. This is coming. Don’t stress yourself with short term dates, SP and media coverage. We are currently producing viral penicillin for every nuclear bunker in every country.
And best of all, it’s under the market’s radar. So fill your boots now, relax and enjoy the reaction when everyone else clocks it.
Org - he said no RNS announcing/about the actual webinar, as there will be no news that isn’t in an RNS. That would still be true if an RNS came out before the webinar and RM talked about that news...
Hey whiney, you are right. This share is a dud in a global pandemic. We have all patiently tried to answer your questions but I can see it’s not helping, so why don’t you listen to your own advice, sell up and move along.
The sharesoc site now says “ Due to exceptional demand, we can no longer guarantee that new members will receive their welcome packs in time to register for this event”
So get in there quickly.
Sharesoc didn’t expect us lot to turn up in such numbers!
https://www.sharesoc.org/events/sharesoc-webinar-with-synairgen-sng-18-november-2020/
Here’s the latest video link Punit. Lots of clues to trial speed and potential “partnering”.
https://www.reddit.com/r/synairgen/comments/jfe6hm/synairgen_close_80m_share_sale_to_fund_crucial/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
Punit, seriously, watch the last interactive investor video. It’s on the reddit site.
RM himself said only a fool would predict when an international trial would complete. However I think you can look at the global covid figures and say- it will be fast.
Morning Monsieur Big,
There is a “signet” discussion afterwards. I’m not sure if RM is still there or whether it is just investors. If you go to the event page, you should be able to register. You have to register separately for both sessions.
Where’s the optimism of yesterday gone?
We now know there is a UK trial of 900 patients in 20 hospitals. It will take a few weeks to fill at tragically 1600 hospital admissions per day. This is proof that the UK want to approve this drug.
It has been updated on the NIHR website, so only a matter of time before a press release or RNS.
Stop watching the share price, unless you want to sell today. We clearly know something that the market doesn’t. Yet.
For any last minute joiners for tonight. You have to register for sharesoc membership (free) which takes a while, and then register for the webinar and the discussion afterwards separately.
Sharesoc could have their biggest webinar ever!